Aarti Pharmalabs Limited has informed the Exchange regarding 'Machine Readable copy of Financial Results for the quarter and financial year ended March 31, 2025'.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aarti Pharmalabs Limited has filed the machine-readable copy of its financial results for the fourth quarter and full financial year ended March 31, 2025 with the stock exchange. This is a standard procedural filing required for exchange records and does not by itself contain the actual financial figures or performance details. Investors should refer to the company's detailed results announcement or annual report for the actual numbers, segment performance, and management commentary. The filing simply confirms that the structured, machine-readable version of the results has been submitted as per exchange requirements.
This filing is procedural in nature and is not expected to have any direct impact on the stock price or shareholder value on its own. The actual financial performance will be assessed when the detailed results are published and analysed.